Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Early-stage Dupuytren's disease treatment; a promising next step?

Journal article

Selles R., (2022), The Lancet Rheumatology, 4, e377 - e378

MODELLING OF UK GENERAL POPULATION UTILITY: THE ALDVMM APPROACH IN PRACTICE

Conference paper

Chang-Douglass S. et al, (2022), VALUE IN HEALTH, 25, S356 - S357

RATIONING IN AN ERA OF MULTIPLE TIGHT CONSTRAINTS: IS COST-UTILITY ANALYSIS STILL FIT FOR PURPOSE?

Conference paper

Dakin H. and Tsiachristas A., (2022), VALUE IN HEALTH, 25, S7 - S7

Trends in mortality among people with diagnosed type 2 diabetes in Malaysia: 2010-2019

Conference paper

Lin LL. et al, (2022), DIABETES RESEARCH AND CLINICAL PRACTICE, 186

The use of patient-reported outcome measures to guide referral for hip and knee arthroplasty.

Journal article

Price AJ. et al, (2020), Bone Joint J, 102-B, 941 - 949

The use of patient-reported outcome measures to guide referral for hip and knee arthroplasty.

Journal article

Dakin H. et al, (2020), Bone Joint J, 102-B, 950 - 958

Load More